2 reports

  • Administration (FDA) has granted orphan drug designation to BDM-E for the treatment of Retinitis Pigmentosa.

In August, the company secured European patent for its synthetic antimicrobial compound BDM-##.

  • Pharmaceutical
  • Vaccine
  • United States
  • Company
  • BioDiem Ltd
  • BIODIEM, LTD.
  • Target

COMPANY INFORMATION: PARTNERS PARTNER ##: GENZYME CORPORATION PARTNERSHIP Industry Address City State Country Website Phone number Pharmaceuticals and Healthcare--> Therapy Area--> Central Nervous System Pharmaceuticals and Healthcare--> Therapy Area--> Oncology

  • Pharmaceutical
  • Vaccine
  • China
  • Company
  • BioDiem Ltd